Industry Connect

Please Note: If you consent to have your badge scanned by a sponsor or at a sponsor-branded session, you are requesting Endocrine Society share your information - as it was provided during the registration process - with that sponsor so they may contact you for marketing purposes. This is optional - you may choose not to offer your badge. Please be aware that providing the sponsor with your information may involve transferring it to another country. For questions about how the sponsor will handle your information or to unsubscribe from their marketing communications, please contact the sponsor directly or refer to its privacy policy. For questions related to how the Endocrine Society shares information, please refer to the Endocrine Society's Privacy Policy.

All events take place in the Industry Connect Area

Saturday, July 12
10:30–11:00 AM PT

Sponsor: IBSA USA

Beyond the Numbers: Unmasking the Symptom Gap in Hypothyroidism Management

Clinicians treating hypothyroidism today face a critical challenge of managing persistent hypothyroid symptoms in patients with normal TSH levels following treatment. This clinical challenge is an opportunity to rethink the current treatment paradigm. Focusing on individualized patient care, the session will guide healthcare professionals in identifying and addressing the symptom management gaps in hypothyroidism treatment. Participants will learn comprehensive strategies to recognize patients experiencing ongoing symptoms despite standard levothyroxine treatment, investigate potential underlying factors contributing to persistent symptoms, and explore differences in treatment formulations. Through interactive case discussions and practical guidance, the session aims to enhance clinicians’ ability to provide comprehensive, personalized care for patients with hypothyroidism.

Speaker:
Rosemarie Lajara, MD

TEDucation Challenge

How much do you really know about Thyroid Eye Disease (TED)? Come test your knowledge at the ENDOExpo and take part in the TEDucation Challenge. Join board certified endocrinologists and fellows to compete to see who knows more about TED, a condition that can impact up to 40% of those living with Graves’ disease. Understand how to spot and identify the signs and symptoms in your patients. Your participation will earn a donation to a TED patient advocacy organization. Ready to play?

Speaker:
Margarita Ochoa-Maya, MD

Diagnosis and Treatment of Severe Primary IGF-1 Deficiency (SPIGFD)

How to diagnosis Severe Primary IGF-1 Deficiency (SPIGFD)
Safety and Efficacy of Increlex (mecasermin)
Appropriate Utilization and Dosing of Increlex (mecasermin)

Speaker:
Philippe Backeljauw, BSC, MD